|
|
Line 12: |
Line 12: |
|
| |
|
|
| |
|
| ===2021: Testimony in Netherlands pertaining to a potential flavour / flavor ban: [https://www.clivebates.com/documents/NLFlavoursResponseJan2021.pdf Regulation of e-cigarette flavours – a response]=== | | ===2021: [https://www.clivebates.com/documents/NLFlavoursResponseJan2021.pdf Regulation of e-cigarette flavours – a response]=== |
| | *Testimony in Netherlands pertaining to a potential flavour / flavor ban. This document responds to the proposed Decree of the State Secretary for Health, Welfare and Sport on the regulation of e-cigarette flavours in the Netherlands. |
| *Signed by 24 experts from around the world | | *Signed by 24 experts from around the world |
| *Covers 12 key points including dual use | | *Covers 12 key points |
| | **Sets conflicting objectives and takes a “war on drugs” approach to nicotine. |
| | **Adopts false and misleading claims about the risks of e-cigarettes. |
| | **Draws on irrelevant information about an outbreak of lung injuries in North America. |
| | **Misunderstands “dual-use”. |
| | **Asserts a “gateway effect” but there is more likely to be a diversion away from smoking. |
| | **Takes a simplistic approach to youth risk behaviours and fails to demonstrate benefits to adolescent public health. |
| | **Ignores perverse consequences of prohibition, even though these are foreseeable. |
| | **Fails to show benefits for adolescents or address concerns it may cause harm to young people. |
| | **Ignores the harmful effects of a vaping flavour ban on adults. |
| | **Creates regulatory protection for the cigarette trade. |
| | **Violates important regulatory principles, including those underpinning the European Union internal market. |
| | **Proposes an illiberal policy and fails to recognise a major global public health opportunity. |
| | *Acknowledgement: We confirm that signatories report no conflicts with respect to FCTC Article 5.3 and no financial conflicts of interest with respect to tobacco or e-cigarette companies under the International Committee of Medical Journal Editors (ICJME) reporting standard. |
|
| |
|
|
| |
|